Male ductal carcinoma in situ: diagnosis and management of a rare disease in men.
| Autor: | Tian C; Internal Medicine, Rush University Medical Center, Chicago, Illinois, USA changtai_tian@rush.edu., Alvarado R; Internal Medicine, Rush University Medical Center, Chicago, Illinois, USA., Kim T; Internal Medicine, Rush University Medical Center, Chicago, Illinois, USA., Slostad J; Internal Medicine, Rush University Medical Center, Chicago, Illinois, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | BMJ case reports [BMJ Case Rep] 2024 Mar 18; Vol. 17 (3). Date of Electronic Publication: 2024 Mar 18. |
| DOI: | 10.1136/bcr-2023-256608 |
| Abstrakt: | Ductal carcinoma in situ is very rare in male patients, accounting for approximately 5%-7% of all male breast cancers. We present a case of a man in his early 70s who presented with bloody nipple discharge and gynaecomastia and was subsequently diagnosed with ductal carcinoma in situ (DCIS). We discuss his management with surgical resection and the consideration of adjuvant treatment. We also review the existing literature on the presentation, diagnosis and management of DCIS in men. Competing Interests: Competing interests: None declared. (© BMJ Publishing Group Limited 2024. No commercial re-use. See rights and permissions. Published by BMJ.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|